684 results on '"Claessen, Bimmer E"'
Search Results
102. Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 Years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry
103. Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions
104. Adjunctive thrombus aspiration versus conventional percutaneous coronary intervention in ST-elevation myocardial infarction
105. The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock
106. Identification and treatment of the vulnerable coronary plaque.
107. Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
108. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial
109. Comparison of Long Term Clinical Prognosis after Primary Percutaneous Coronary Intervention according To the Presence Of In-hospital Major Bleeding Events: 3 Year Follow-up Result Of HORIZONS-AMI Trials: A-013
110. Considerations for Optimal Device Selection in Transcatheter Aortic Valve Replacement
111. FFR in the Setting of ACS
112. Improving the Design of Future PCI Trials for Stable Coronary Artery Disease
113. Safety and efficacy of the bioabsorbable polymer everolimus‐eluting stent versus durable polymer drug‐eluting stents in high‐risk patients undergoing PCI : TWILIGHT‐SYNERGY
114. Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion—A subanalysis of the EXPLORE trial
115. Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
116. Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies
117. Impact of insulin treated and non‐insulin‐treated diabetes compared to patients without diabetes on 1‐year outcomes following contemporary PCI
118. Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)
119. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry
120. The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial
121. Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction
122. Current status of the Xience V® everolimus-eluting coronary stent system
123. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial
124. Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes
125. The Doppler flow wire in acute myocardial infarction
126. The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement.
127. Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial.
128. Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion—A subanalysis of the EXPLORE trial.
129. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry.
130. Collateral Quality Decay Several Days After Primary Percutaneous Coronary Intervention: A Unique Observation From the EXPLORE Trial
131. Reply: Paclitaxel-Eluting Balloons or Everolimus-Eluting Stents for In-Stent Restenosis
132. Revascularization Strategies in Cardiogenic Shock Patients With MVD: For Now, Keep it Simple
133. Go With the Flow When Instantaneous Wave-Free Ratio-Fractional Flow Reserve Discordance Occurs: Indeed, Beware When Relying on Fractional Flow Reserve Alone
134. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
135. Impact of stent diameter on outcomes following percutaneous coronary intervention with second‐generation drug‐eluting stents: Results from a large single‐center registry
136. Minding the Microcirculation
137. Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
138. Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration
139. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial
140. Exercise testing after chronic total coronary occlusion revascularization in patients with STEMI and a concurrent CTO: A subanalysis of the EXPLORE‐trial
141. Hope for the best, prepare for the worst: How to manage coronary perforations
142. 600.09 In-Hospital Outcomes of Patients with Bicuspid Aortic Valve Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Analysis
143. Association between proton pump inhibitor and ischemic stroke risk remains controversial
144. Leave nothing behind: Promising results for coronary drug‐coated balloons in clinical practice
145. Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies
146. Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention
147. Mid- and long-term outcome of the EXPLORE trial, a Global, Randomized, Prospective, Multicenter Trial Investigating the Impact of Recanalization of a Chronic Total Occlusion in Patients after Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction
148. Go With the Flow When Instantaneous Wave-Free Ratio-Fractional Flow Reserve Discordance Occurs
149. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions
150. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.